Supplement × Prescription·a caution·Emerging evidence

Quercetin + Roflumilast

Caution Emerging evidence

Quercetin can inhibit some CYP enzymes and transporters in vitro, which could make roflumilast tolerability less predictable.

From the database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, and the recommendation.

Substances
Pair type
Caution
Evidence
Emerging
Source citations
1
Scope
Supplement × Prescription
Last verified
June 4, 2026
CautionEmerging evidence

What is happening. Quercetin can inhibit some CYP enzymes and transporters in vitro, which could make roflumilast tolerability less predictable.

Mechanism. Potential modulation of CYP3A4, CYP1A2, or transporters involved in roflumilast disposition.

Recommendation. Use cautiously when starting or stopping high-dose quercetin; monitor diarrhea, nausea, weight loss, and mood symptoms.

Stack Score

How it moves the number.

Effect on the composite score

If both Quercetin and Roflumilast are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.

Sources

Sources, by evidence tier.

Every claim on this page is cited. PMIDs link straight to PubMed.

Reference material

1
  • 1U.S. National Library of Medicine. Roflumilast Tablets US Prescribing Information. 2026.Needs sourceNo link

Check your full routine

One pair was the worked example.

Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.